安徽皖维高新材料股份有限公司 关于召开 2023 年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 至 2023 年 10 月 13 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按照《上海证券交易所上市公司自律监管指引第 1 号 — 规范运 作》等有关规定执行。 证券代码：600063 证券简称：皖维高新 公告编号：2023-026 股东大会召开日期：2023年10月13日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一) 股东大会类型和届次 2023 年第一次临时股东大会 (二) 股东大会召集 ...

证券代码：600063 股票简称：皖维高新 编号：临 2023-023 安徽皖维高新材料股份有限公司 八届二十九次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担个别及连带责任 一、董事会会议召开情况 安徽皖维高新材料股份有限公司董事会八届二十九次会议，于 2023 年 9 月 21 日在公司研发中心七楼高管会议室召开，本次会议应 到董事 9 人，实际到会 9 人。会议由董事长吴福胜先生主持，公司 监事、部分高级管理人员列席了本次会议。本次会议的召开及程序 符合《公司法》和《公司章程》的有关规定。本次会议经过充分讨 论，以记名投票表决方式进行了表决，审议通过了本次会议的各项 议案。 （一）审议通过了《关于投资新建年产 2000 万平方米 TFT 偏 光片用宽幅聚乙烯醇光学薄膜项目的议案》（同意 9 票，反对 0 票， 弃权 0 票） 聚乙烯醇（PVA）光学薄膜是制造偏光片的核心材料，偏光片 约占 TFT-LCD（薄膜晶体管液晶显示器）面板成本的 10%左右，全 球大尺寸偏光片市场每年销售额近百亿美元。在偏光片所需的各类 ...

安徽皖维高新材料股份有限公司 董事会提名委员会决议 2023 年 9 月 21 日，安徽皖维高新材料股份有限公司董事会提名 委员会召开会议，审议了《关于解聘张东华先生公司副总经理职务的 议案》，经过审查，认为：因张东华先生已到法定退休年龄，公司决 定解聘其副总经理职务，符合《公司法》、《上市公司治理准则》等法 律法规的有关规定。董事会提名委员会同意该议案提请公司八届二十 九次董事会审议及解聘。 安徽皖维高新材料股份有限公司 董事会提名委员会 2023 年 9 月 21 日 召集人：崔 鹏 成 员：吴福胜 毛献伟 戴新民 尤 佳 ...

安徽皖维高新材料股份有限公司独立董事 关于投资新建年产2000万平方米TFT偏光片用宽幅聚乙烯 醇光学薄膜项目的独立意见 根据中国证监会《关于在上市公司建立独立董事制度的指导意 见》、《上市公司独立董事管理办法》、《上市公司治理准则》、《上海证 券交易所上市规则》、《上海证券交易所上市公司自律监管指引第1号 ——规范运作》等法律、法规和规范性文件及《公司章程》的相关规 定，作为安徽皖维高新材料股份有限公司独立董事，我们本着审慎负 责的态度，已事前审阅认可了《关于投资新建年产2000万平方米TFT 偏光片用宽幅聚乙烯醇光学薄膜项目的议案》，经过认真讨论，发表 如下独立意见： 投资新建年产 2000 万平方米 TFT 偏光片用宽幅聚乙烯醇光学薄 膜项目符合国家产业政策，具有良好的投资效益、社会效益和抗风险 能力。项目利用新装备、新工艺、新技术开发符合市场需要的高附加 值产品，在引领国内 PVA 光学薄膜行业技术与产品创新，促进液晶 显示产业结构调整方面具有重大意义。项目建成达产后，既能进一步 丰富公司产品链，又可培育公司新的利润增长点，有助于公司的可持 续、高质量发展，符合公司的长远发展规划，同时也符合上市公司及 ...

证券代码: 600063 证券简称:皖维高新 安徽皖维高新材料股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|----------------------------------|--------------------------| | 投资者关系活动 | □特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 √ | 业绩说明会 | | | □ 新闻发布会 | 路演活动 | | | □ 现场参观 | | | | □ 其他 | (请文字说明其他活动内容) | | 参与单位名称及 | 投资者网上提问 | | | 人员姓名 | | | | 时间 | 2023 年 9 月 12 日 ( | 周二) 下午 14:00~17:30 | | 地点 | | https://ir.p5w.net | | | 采用网络远程的方式召开业绩说明会 | | | 上市公司接待人 | 1、董事、总经理、财务总监孙先武 | | | 员姓名 | 2、董事会秘书史方圆 | | 3、证券部部长王军 投资者提出的问题及公司回复情况 公司就投资者在本次说明会中提出的问题进 ...

Group 1: Event Details - The company will participate in the "2023 Anhui Listed Companies Investor Collective Reception Day" organized by Anhui Securities Regulatory Bureau, Anhui Listed Companies Association, and Shenzhen Panorama Network Co., Ltd. [2] - The event will be held online on September 12, 2023, from 14:00 to 17:30, with the interactive session from 15:30 to 17:30 [2] - Investors can participate via the "Panorama Roadshow" website, WeChat public account, or by downloading the Panorama Roadshow APP [2] Group 2: Communication Topics - Company executives will discuss the 2023 semi-annual performance, corporate governance, development strategy, operational status, financing plans, equity incentives, and sustainable development [2] - The company encourages active participation from investors during the online communication session [2] Group 3: Company Assurance - The board of directors guarantees that the announcement contains no false records, misleading statements, or significant omissions, and they assume responsibility for the truthfulness, accuracy, and completeness of the content [2]

证券代码：600063 股票简称：皖维高新 编号：临 2023-021 安徽皖维高新材料股份有限公司 产研院的组建旨在加快突破先进功能膜制造的技术壁垒，打破 我国新型显示和新能源汽车等战略新兴产业的"膜"咒，实现自主 可控，保障产业链、供应链安全。 产研院的组建不会对公司近期的生产经营产生重大影响。敬请 广大投资者理性投资，注意投资风险。 特此公告 安徽皖维高新材料股份有限公司 董 事 会 关于获批组建"先进功能膜材料安徽省产业创新研究院" 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担个别及连带责任 近日，安徽皖维高新材料股份有限公司（以下简称"公司"） 收到安徽省科学技术厅下发的《关于立项组建首批安徽省创新研究 院的通知》（皖科基地秘〔2023〕287 号），同意公司牵头组建"先 进功能膜材料安徽省产业创新研究院"（以下简称"产研院"）。 产研院的功能定位为聚焦先进功能膜材料的树脂原料合成、成 膜加工与下游应用，通过与高校、科研机构和产业链上下游企业合 作，建设集研发、中试、转化、孵化为一体的综合性创新平台，打 造成为国内 ...

Impairment Testing and Asset Valuation - The company does not amortize intangible assets with uncertain useful lives and reviews their useful lives annually[2]. - Long-term equity investments are tested for impairment, and if recoverable amounts are below book values, impairment losses are recognized[4]. - The company conducts impairment tests on fixed assets and recognizes impairment losses if recoverable amounts are lower than book values[4]. - The company has a policy for testing impairment of intangible assets, recognizing losses when recoverable amounts fall below book values[7]. - Goodwill is tested for impairment at least annually, with losses recognized if the recoverable amount of related asset groups is below their book value[7]. - The company recognizes expected liabilities when obligations meet specific criteria, including the likelihood of economic outflow and reliable measurement[19]. - The company will recognize impairment losses for contract costs when their carrying amount exceeds the expected remaining consideration from related goods or services[26]. - The company has not reported any new impairment provisions during the period, maintaining the book value of its assets[181]. Revenue Recognition - Revenue is recognized when the company fulfills performance obligations, with specific conditions for domestic and international sales[22]. - The company allocates transaction prices to performance obligations based on standalone selling prices and recognizes revenue accordingly[22]. - The company does not apply different accounting policies for revenue recognition across similar businesses[23]. - The company recognizes contract costs based on the same basis as the revenue recognition of related goods or services, with amortization for costs not exceeding one year recorded in the current profit and loss[26]. Employee Compensation and Benefits - Short-term employee compensation is recognized as liabilities in the period services are provided, including wages, bonuses, and benefits[10]. - The company recognizes employee compensation related to accumulated paid leave rights based on expected payment amounts[12]. - The company recognizes employee benefits liabilities based on the defined contribution plan and measures them at present value using discount rates aligned with government bonds or high-quality corporate bonds[13]. - For defined benefit plans, the company estimates obligations using actuarial assumptions and discounts them to determine the present value of the obligations and current service costs[13]. - The company confirms termination benefits when it cannot unilaterally withdraw from the plan or when it recognizes costs related to restructuring[14]. - Other long-term employee benefits are measured at present value, including service costs and interest on net liabilities or assets[18]. Taxation and Deferred Tax Assets - Deferred tax assets are confirmed based on the probable taxable income, reducing the income tax expense in the current profit and loss statement[31]. - The company will recognize deferred tax assets related to deductible temporary differences from acquired entities if new information indicates realizable economic benefits within 12 months post-acquisition[31]. - The company applies the balance sheet liability method to recognize and measure deferred tax liabilities or assets based on temporary differences between the book value and tax base of assets and liabilities as of the balance sheet date[36]. - Deferred tax assets are recognized for deductible temporary differences, limited to the amount of future taxable income that is likely to be available to offset these differences[36]. - The company reviews the carrying amount of deferred tax assets at the balance sheet date and reduces the carrying amount if it is unlikely to obtain sufficient taxable income in future periods[36]. Financial Performance and Position - The company's operating revenue for the first half of 2023 was approximately CNY 4.56 billion, a decrease of 9.85% compared to the same period last year[106]. - The net profit attributable to shareholders for the same period was approximately CNY 346.78 million, down 64.24% year-on-year[106]. - The net cash flow from operating activities was approximately CNY 188.78 million, a significant decrease of 87.83% year-on-year[106]. - Total assets at the end of the reporting period reached approximately CNY 14.45 billion, an increase of 9.07% compared to the end of the previous year[106]. - The company's net assets attributable to shareholders were approximately CNY 7.79 billion, showing a slight increase of 0.61% from the previous year[106]. - The current ratio at the end of the reporting period was 1.18, down 4.07% from the previous year[107]. - The debt-to-asset ratio increased to 45.79%, up 4.59% compared to the previous year[107]. - EBITDA interest coverage ratio was 18.83, a decrease of 42.77% year-on-year[107]. Accounts Receivable and Bad Debt Provisions - The accounts receivable notes decreased by 30.86% compared to the end of 2022, primarily due to a reduction in the amount of outstanding notes[59]. - The total accounts receivable at the end of the period amounted to ¥1,247,849,913.39, with bank acceptance bills accounting for the entire amount[65]. - The company reported a total bad debt provision of ¥176,941,639.45, with a beginning balance of ¥182,887,984.73 and a provision of ¥2,662,938.47 during the period[73]. - The actual write-off of accounts receivable during the period was ¥8,609,283.75, attributed to expected uncollectibility[74]. - The aging analysis shows that accounts receivable within one year totaled ¥638,792,201.32, representing 80.0% of the total[68]. - The company has a bad debt provision ratio of 4.03% for accounts receivable aged 1-2 years, and 10.00% for those aged 2-3 years[72]. - The total balance of accounts receivable was ¥797,772,772.19, with a bad debt provision of ¥176,941,639.45, indicating a provision coverage ratio of approximately 22.15%[69]. - The company has recognized a total of ¥150,843,667.00 in bad debt provisions for specific overdue receivables, with a 100% provision rate[69]. Inventory and Prepayments - The total inventory balance as of June 30, 2023, was CNY 1,175,332,258.84, an increase from CNY 908,092,626.83 at the beginning of the period[119]. - The total prepayments at the end of the period were ¥270,518,970.65, an increase from ¥216,256,007.49 at the beginning of the period, reflecting a growth of about 25.1%[81]. - Prepayments within one year accounted for 79.20% of total prepayments, up from 76.16% at the beginning of the period[81]. Research and Development - The company’s R&D investment reached 390 million yuan, with an R&D intensity of 7.38%, and it applied for local financial subsidies amounting to 91.17 million yuan[160]. - The company has organized 81 R&D projects focusing on new product development and technology application, with a budget of 673 million yuan for the year[160]. - The company is actively investing in R&D for specialty PVA products, filling several domestic gaps in the market[144]. Market and Production Insights - The actual production of polyvinyl alcohol (PVA) in China for the first half of 2023 was approximately 400,000 tons, making it the largest producer globally[140]. - The company’s PVA product output reached 119,300 tons, with sales volume at 107,900 tons and sales revenue of 1,352.68 million yuan, with new specialty products accounting for 77.88% of sales[145]. - The company is focusing on expanding its product lines and enhancing its industrial chain, which includes the development of high-strength and high-modulus PVA fibers[145]. - The company has identified new growth opportunities in downstream industries such as optical films, PVB films, and biodegradable materials, which are experiencing rapid development[144]. Financial Management and Risk - The company has disclosed potential risks in the report, advising investors to be cautious[92]. - The report has not been audited, ensuring that the financial statements are accurate and complete[89]. - The company has confirmed no non-operating fund occupation by controlling shareholders or related parties[92]. - The company has not violated decision-making procedures for external guarantees[92]. - The company has strengthened accounts receivable collection efforts, with a focus on tracking and managing overdue accounts[165]. - The company has implemented a dual prevention system for safety and environmental management, enhancing digital management capabilities[165].

证券代码：600063 股票简称：皖维高新 编号：临 2023-018 安徽皖维高新材料股份有限公司 八届二十八次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担个别及连带责任 一、董事会会议召开情况 安徽皖维高新材料股份有限公司下设的分支机构"铁路轨道衡 计量站"成立于 2007 年 3 月 12 日，主要负责铁路轨道衡计量经营。 根据公司"腾笼换鸟"和高质量转型发展的需要，目前自营铁路已 经拆除，计量站处于停用状态。 安徽皖维高新材料股份有限公司（以下简称："公司"）董事会 八届二十八次会议于 2023 年 8 月 9 日在公司研发中心 6 楼百人会议 室召开。本次会议应到董事 9 人，实际到会 8 人，董事张正和先生 因工作原因未能出席现场会议，委托董事孙先武先生代为行使表决 权并签署相关文件。本次会议由董事长吴福胜先生主持，公司监事、 部分高级管理人员列席了会议。本次会议的召开及程序符合《中华 人民共和国公司法》和《公司章程》的有关规定。本次会议经过充 分讨论，以记名投票表决方式进行了表决，审议通过了相关议案。 ...

安徽皖维高新材料股份有限公司 2023 年度超额利润分享实施细则 一、三年目标利润规划完成情况 按照《安徽皖维高新材料股份有限公司超额利润分享方案》 要求，公司在三年计划期内目标利润计划保持稳定增长。 2023 年度净利润考核目标值为 109642 万元。 二、年度超额利润分享适用条件 1、安徽皖维高新材料股份有限公司（以下简称"皖维高新" 或"公司"）为商业一类企业，"科改示范行动"试点企业，符合 相关政策要求，具备开展超额利润分享方案条件。 2、公司年度利润创造能力与战略发展要求匹配，满足本年 度对目标利润的考核要求。 3、公司建立健全的法人治理结构，人力资源管理基础完善， 财务管理制度规范，近三年没有因财务、税收等违法违规行为受 到行政、刑事处罚。 三、2023年度目标利润计算基础 （一）年度利润考核目标 （二）按照公司上一年净资产收益率计算的利润水平 考虑相关影响因素后，按照上一年净资产收益率测算 2023 年度公司净利润为 154,604 万元（上一年净资产收益率 17.58%， 2023 年底净资产预算 879,431 万元）。 （三）近三年企业实际利润金额 2020-2022 年公司主营业务发展 ...